LYRA - Total Utang marang Modal Lyra Therapeutics Inc

Logo perusahaan publik Lyra Therapeutics, Inc. (LYRA)

Lyra Therapeutics, Inc. (LYRA) brings together top-tier drug delivery specialists attracted by competitive compensation and the opportunity to achieve a breakthrough in otolaryngology. The business relies on the stable US legal environment, where ethical standards minimize political risks. The development of ENT products is based on the outsourcing of trials and manufacturing. This price chart reflects a total debt-to-equity ratio of 0.00.

LYRA: Total Utang marang Modal Lyra Therapeutics 04.07.2022 - 28.03.2026

Rincian analitis perusahaan Lyra Therapeutics, Inc.

- rega lan prakiraan konsensus rega:
Bagan rega Lyra Therapeutics|LYRA - Bagan tingkat prakiraan
- statistik kapitalisasi pasar:
Kapitalisasi pasar Lyra Therapeutics|LYRA - Nilai Dipunlarasaken Utang lan Kas
- indikator kapitalisasi buku:
Nilai Buku saben Saham Lyra Therapeutics|LYRA - Kapitalisasi Buku|Rasio Nilai Pasar marang Nilai Buku lyratherapeutics.com|LYRA - Nilai Agregat Aset
- indikator total utang lan likuiditas perusahaan:
Utang marang Ekuitas Lyra Therapeutics, Inc.|LYRA - Rasio utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal Lyra Therapeutics, Inc.|LYRA - Gunggung utang perusahaan|Utang marang nilai buku Lyra Therapeutics|LYRA - Silihan lan utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Lyra Therapeutics|Indikator likuiditas cepet lyratherapeutics.com
- informasi bathi lan kelipatan valuasi:
LYRA - Bathi sawise mbayar pajeg
Analisis dhasar perusahaan:Lyra Therapeutics
Barang utama Lyra Therapeutics Inc

To build a resilient portfolio, I assess business dependence on creditors via the total liabilities-to-equity ratio, which determines the issuer's financial autonomy. In the case of Lyra Therapeutics, Inc. (LYRA), low leverage combined with the high pricing power of the unique XTreo matrix minimizes debt service risks, as evidenced by the stable ratio of debt to equity.

Analisis pesaing Lyra Therapeutics, Inc.

Utang marang Ekuitas Haleon|Kenvue Inc - Utang Agregat marang Ekuitas|Total Utang marang Modal VRNA|MENS (Jyong Bio) - Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal LGND (Ligand Pharmaceuticals)|Total Utang marang Modal amneal.com AMRX|PRGO - Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi ALVO (Alvotech S.A.)|Liquidia Technologies (LQDA) - Utang marang Ekuitas|Rasio Total Utang marang Ekuitas Galapagos Corp|ANIP (ANI Pharmaceuticals) - Total Utang marang Modal|Total Utang marang Modal mannkindcorp.com|Rasio Total Utang marang Ekuitas AMPH (Amphastar Pharmaceuticals, Inc.)|PCRX (Pacira Pharmaceuticals) - Rasio Kabeh Utang marang Dana Pribadi|Utang marang Ekuitas ARS Pharma SPRY|Theravance Corp (TBPH) - Utang marang Modal|AQST: Rasio Total Utang marang Ekuitas|scPharmaceuticals Inc. - Utang Agregat marang Modal|TECX: Total Utang marang Modal|Tonix Pharma - Rasio Kabeh Utang marang Dana Pribadi|SXTC (SXT Pharmaceuticals) - Total Utang marang Modal|Utang marang Modal Eupraxia Pharma EPRX|Utang marang Ekuitas BioHarvest Sciences (BHST)|EXOZ (invizyne.com) - Rasio Kabeh Utang marang Dana Pribadi|Utang marang Ekuitas Oramed Pharmaceuticals Inc. ORMP|Entera Bio Ltd - Utang marang Ekuitas|HYFT: Rasio Total Utang marang Ekuitas|Utang marang Modal ABVC BioPharma, Inc|Cumberland Pharmaceuticals (CPIX) - Utang marang Ekuitas|quantumbiopharma.com - Rasio Kabeh Utang marang Dana Pribadi|FGEN (FibroGen) - Total Utang marang Modal|Total Utang marang Modal Telomir Pharmaceuticals Inc|Rasio Total Utang marang Ekuitas RANI (Rani Therapeutics)|SNYR (synergychc.com) - Rasio Kabeh Utang marang Dana Pribadi|Rallybio - Rasio Total Utang marang Ekuitas|Utang Agregat marang Modal LEXX (Lexaria Bioscience Corp)|Pulmatrix - Total Utang marang Modal|Rasio Kabeh Utang marang Dana Pribadi PTHL (Pheton Holdings Ltd)|APM: Total Utang marang Modal|Utang marang Modal Impact BioMedical, Inc. (IBO)|Utang marang Ekuitas TNF Pharmaceuticals Inc.|YCBD: Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal PRFX|Total Utang marang Modal altamiratherapeutics.com (CYTO)|Utang marang Ekuitas Lipella LIPO|OPTN (OptiNose Corp) - Utang Agregat marang Ekuitas|Pieris Pharmaceuticals - Total Utang marang Modal|Utang marang Modal procapsgroup.com|PTPI (Petros Pharmaceuticals, Inc.) - Rasio Total Utang marang Ekuitas|Qilian International Holding Group (QLI) - Total Utang marang Modal|Rasio Total Utang marang Ekuitas SLRN|TFFP (TFF Pharmaceuticals, Inc) - Utang Agregat marang Modal